Stay updated on VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Sign up to get notified when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Locations section added with state-level site listings (Florida, Georgia, Indiana, Kansas, Louisiana, Missouri, New York, North Carolina, Rhode Island, South Carolina, Texas, Utah). Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure element.
    Difference
    1%
    Check dated 2025-12-24T14:34:41.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    43 days ago
    Change Detected
    Summary
    Minor editorial updates: the Publications disclaimer was reworded from 'study results' to 'results of the study', and the revision tag changed from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:45:43.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The government funding status banner warning about potential delays and operating status has been removed from the page.
    Difference
    0.3%
    Check dated 2025-11-17T17:23:35.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The latest view shows minor layout refinements and reformatting of sections, with no changes to the study title, description, eligibility criteria, primary/secondary outcomes, or listed locations. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T09:56:42.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    The page now communicates a funding-related operating-status notice and confirms the center is open, plus a new version identifier v3.2.0, replacing v3.1.0.
    Difference
    3%
    Check dated 2025-10-05T14:29:43.000Z thumbnail image
  9. Check
    100 days ago
    Change Detected
    Summary
    Updated the page from v3.0.2 to v3.1.0, signaling a new software release version.
    Difference
    0.1%
    Check dated 2025-09-28T09:46:58.000Z thumbnail image

Stay in the know with updates to VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.